Integrated Genomics of Breast Cancer
Our research program is focusing on the molecular biology of breast and ovarian cancer with emphasis on identification of genotypes and gene expression profiles contributing to elevated cancer risk, radiation sensitivity, tumor aggressiveness and therapy resistance.
 | Anne-Lise Børresen-Dale's research group is currently focusing on:
|
 | Anne-Lise Børresen-Dale is chair of the 21st biennial Meeting of the EACR, which is held Oslo, Norway, 26-29 June, 2010. Conference web page - click here. |
Contact information:
Department of Genetics, Institute for Cancer Research
The Norwegian Radium Hospital, N-0310 Oslo,Norway
Phone: +47 2278 1333, Fax: +47 2278 1395, Switchboard: +47 2293 4000
Print this page [8804 visits]Mar 8, 2010
21st Meeting of the European Association for Cancer Research, 26 - 29 June 2010
Feb 25, 2010
Latest publications
Anne-Lise Børresen-Dale
SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance
Pharmacogenomics J (in press)
PubMed 20157331
Epithelial-Stromal Interaction 1 (EPSTI1) Substitutes for Peritumoral Fibroblasts in the Tumor Microenvironment
Am J Pathol (in press)
PubMed 20133812
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study
Hum Mutat, 31 (3), E1200-40
PubMed 20104584
More publications
